Pfizer expects record profits in 2022 due to its COVID-19 shots and antiviral medication. Its treatment failures, necessitating boosters and multiple courses of treatment, allows it to double-dip, profiting off both a failed preventative – the shot – and subsequent treatment for the COVID-19 infection it was supposed to prevent.
While the world was plunged into a time of economic instability and panic during the COVID-19 pandemic, pharmaceutical companies like Pfizer made out like bandits and continue to reap the astonishing profits of their ineffective COVID-19 treatments. Ironically, part of what makes the treatments so profitable is the fact that they don’t do what they’re supposed to, which is prevent and effectively treat COVID-19….